Nothing, it seems, lends itself to the aphorism that if-one-doesn’t-like-the-results-of-some-medical-trial-just-wait-a-few-and-you’ll-be-rewarded than the hotly debated issue over whether the pathologic process behind the development of Alzheimer dementia is rooted in chronic inflammation. That day in which the pendulum of scientific thought has swung in the other direction is here — at least for now.

New data is out that supports the notion that not only anti-inflammatories such as naproxen and ibuprofen (two of the most popular) do not prevent the deveopment of dementia, they may also accelerate its course in “older” geriatric patients at the time of diagnosis. | LINK

Related Posts Within Doctor Pundit:

1. Study: Authors Attempt to Characterize Dementia As a Terminal Illness In the upcoming NEJM, a large prospective study makes the...
2. Scientists Find New Avenue in Mechanism of Alzheimer Dementia Development The major focus of research into the biochemical causes and...
3. Study Highlights Possible ‘Nutritional’ Beverage for Dementia A nationwide clinical trial is underway to determine if a...
4. New Dementia Drug in Development Fails Initial Study Pfizer’s current research on a potential blockbuster anti-Alzheimer drug is...
5. Study: Spouses of Dementia Patients May Be at Increased Risk of Incident Dementia Although the prevalence rate of dementia is higher overall in...